Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 625.00 | 270.83 | 691.00 | 644.25 | 1.0726 | 1.1153 |
| BT-20 | Erlotinib | 1 | uM | 8 | 625.00 | 270.83 | 805.00 | 644.25 | 1.2495 | 1.3901 |
| BT-20 | Lapatinib | 10 | uM | 8 | 625.00 | 270.83 | 374.00 | 644.25 | 0.5805 | 0.2945 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 625.00 | 270.83 | 719.00 | 644.25 | 1.1160 | 1.1835 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 625.00 | 270.83 | 763.00 | 644.25 | 1.1843 | 1.2898 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 625.00 | 270.83 | 967.00 | 644.25 | 1.5010 | 1.7676 |
| BT-20 | Lapatinib | 1 | uM | 8 | 625.00 | 270.83 | 828.00 | 644.25 | 1.2852 | 1.4445 |
| BT-20 | Linsitinib | 10 | uM | 8 | 625.00 | 270.83 | 843.00 | 644.25 | 1.3085 | 1.4799 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 625.00 | 270.83 | 792.00 | 644.25 | 1.2293 | 1.3591 |
| BT-20 | Erlotinib | 10 | uM | 8 | 625.00 | 270.83 | 615.00 | 644.25 | 0.9546 | 0.9270 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 625.00 | 270.83 | 849.00 | 644.25 | 1.3178 | 1.4940 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 625.00 | 270.83 | 725.00 | 644.25 | 1.1253 | 1.1981 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 625.00 | 270.83 | 289.00 | 644.25 | 0.4486 | 0.0533 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 625.00 | 270.83 | 606.00 | 644.25 | 0.9406 | 0.9044 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 625.00 | 270.83 | 1004.00 | 644.25 | 1.5584 | 1.8520 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 612.00 | 644.25 | 0.9499 | 0.9195 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 625.00 | 270.83 | 504.00 | 644.25 | 0.7823 | 0.6434 |
| BT-20 | Linsitinib | 1 | uM | 8 | 625.00 | 270.83 | 574.00 | 644.25 | 0.8910 | 0.8236 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 641.00 | 644.25 | 0.9950 | 0.9919 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 390.00 | 644.25 | 0.6054 | 0.3387 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 490.00 | 644.25 | 0.7606 | 0.6068 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 509.00 | 644.25 | 0.7901 | 0.6564 | |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 625.00 | 270.83 | 361.00 | 644.25 | 0.5603 | 0.2584 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 625.00 | 270.83 | 678.00 | 644.25 | 1.0524 | 1.0834 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 625.00 | 270.83 | 588.00 | 644.25 | 0.9127 | 0.8591 |